Campylobacteriosis following immunosuppression for immune checkpoint inhibitor-related toxicity

Five patients receiving checkpoint inhibitor immunotherapy (CPI) under our care across two cancer centers over a 12-month period have subsequently developed campylobacterosis. All had received immune-suppressive treatment for CPI-related colitis in the weeks or months preceding the detection of Camp...

Descripción completa

Detalles Bibliográficos
Autores principales: Lee, Karla A, Shaw, Heather, Bataille, Véronique, Nathan, Paul
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2020
Materias:
Commentary
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7537329/
https://www.ncbi.nlm.nih.gov/pubmed/33020237
http://dx.doi.org/10.1136/jitc-2020-000577

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7537329/
https://www.ncbi.nlm.nih.gov/pubmed/33020237
http://dx.doi.org/10.1136/jitc-2020-000577

Ejemplares similares